Cannabis Goes Green – Eugene Weekly – Eugene Weekly

Emerald Valley Gardens, a small cannabis gardening shop near Springfield, is bustling with customers. At the register, owner Madeline Thomas answers questions about where to find the right pots or which brands to buy for first-time growers. Shelves are lined with nutrients and soil, and draped with leafy trailing plants. 

Thomas has been in the cannabis industry for more than 10 years, and says she loves the business. Over the course of the past two years, she says, her clientele skyrocketed during the COVID-19 pandemic because people had more time on their hands. 

“It’s been so cool,” she says. “We’ve seen people who haven’t ever grown a cannabis plant or ever had a vegetable garden come in here, which is great. They’re our favorite customers because they’re super enthusiastic.” 

According to the medical journal Journal of Addictive Diseases, medicinal cannabis use increased by 91 percent since the COVID-19 pandemic began. Some cannabis users in Eugene have taken to self-growing while stuck at home, which is a more environmentally friendly alternative to purchasing from a large-scale dispensary.

Cannabis consumes a lot of water and energy. Thomas says lighting is one of the most important elements when growing cannabis because the goal is to replicate an outdoor environment in a controlled grow room. Indoor marijuana growth needs complex high-powered lighting systems that require an abundance of energy for use — annually equating to 300 million running vehicles, a total of 1 percent of national energy consumption in the U.S. 

But outdoor growing is not much better. One mature cannabis plant requires 22.7 liters of water per day in comparison to 12.64 liters for a wine grape plant. However, the Oregon Cannabis Environmental Best Practices Task Force also states that cannabis is just another crop, and that its water-use practices can be more efficient. 

Red Cuer, an employee with Emerald Valley Gardens who also started an independent cannabis irrigation company, says the best way for a grower to adapt for a more environmentally friendly cannabis crop is to prioritize soil with good water retention so that the plant has access to water for a longer time. As with any garden, Cuer says that independent cannabis growers get to know how the plant was raised and what kinds of nutrients it receives. 

“There’s a lot to cannabis, especially when it comes to indoor growing, just the sheer amount of electricity and the power draw that it takes. It does have a pretty hefty impact, I would say,” Cuer says. “Trying to focus a little bit more on sustainability would be something I would personally love to see the cannabis industry sort of get a hold of.” 

Enlarge

20210923cannabis-plant-big

Illustration by Chelsea Lovejoy

Jeffrey Steiner, associate director of Oregon State University’s Global Hemp Innovation Center, says there aren’t a lot of studies on how to mass-produce cannabis, specifically hemp, in a sustainable way yet. Hemp and marijuana are both derived from the cannabis species, according to Steiner, but they have different levels of tetrahydrocannabinol (THC). Hemp and marijuana grown for cannabinoids, THC and CBD, are similar in that producers want to optimize the production of flowers where those cannabinoids are concentrated. Hemp has much lower levels of THC.

He says that the idea of finding solutions to some of those issues is imperative as cannabis use increases nationally. 

Steiner says that the innovation center is testing methods to make cannabis production both profitable and sustainable, and that hemp might be a crop of interest as the climate emergency demands drastic changes in energy and water use. 

“We really have to think about how to sustainably incorporate hemp,” he says. “It’s going to take a lot more thinking, investment, creativity and innovation to make it work, but it’s worth pursuing.”

Abundance is also proving to be an issue for large-scale operations where cannabis is grown widely. In 2019, Oregon was producing twice as much cannabis as people were consuming. 

On the small-scale level, independent growing could alleviate cannabis’ overuse of resources that mass-producing farms often cause now, specifically in Oregon. Instead of clearing fields for cannabis production or covering them in single-use plastics, people can use their own backyards, gardens and homes. 

Thomas says people who grow their own gardens typically care about growing them in a way that doesn’t require an abundance of water, energy or pesticide-filled fertilizer. 

“If you’re going to grow your plants, you’re going to probably make less of an impact in every way,” Thomas says. “There’s an emotional bond with cannabis plants that is pretty deep. People often put a lot of love and attention into them.” 

Starting an independent garden of any kind benefits the planet from lessening long-distance transportation for cannabis or food, which is the largest source of fossil fuel emissions globally at 29 percent. Additionally, gardeners can choose to omit the use of pesticides or synthetic chemicals in home-grown produce.  

“I think that people grow their own cannabis because they like to garden,” she says. “That’s the way that I think the cannabis industry can change. It would be great if a lot more stuff was made locally.”

Canton village trustees hear from public on cannabis – NNY360

CANTON — The village Board of Trustees heard from a handful of residents during a virtual hearing regarding the legal sale of marijuana in Canton.

There were 23 people signed into the Zoom meeting, which concluded in just 25 minutes.

Signed into law by Gov. Andrew M. Cuomo in March, the Marijuana Regulation and Taxation Act legalized recreational marijuana sales and use for adults 21 and older. It immediately expunged previous marijuana-related convictions from New Yorkers’ records and established a framework for regulating businesses.

Cities, towns and villages across the state can decide to opt out of allowing dispensaries by passing a local law by Dec. 31, though municipalities would then forego tax revenue generated from shops within their boundaries.

A total 13% cannabis excise tax will apply when dispensary sales begin, likely next year. The tax breaks down into 1% for the county, 3% for the dispensary’s municipality and 9% for the state.

Should the village decide to opt out, village residents could petition for a referendum or the village could hold a referendum of its own volition. Otherwise, dispensaries would be allowed to open once the Marijuana Regulation and Taxation Act’s regulatory mechanisms are further developed.

Most commenters Wednesday night were in favor of allowing sales in Canton.

“Allowing cannabis dispensaries and on-site use in the village of Canton is to the benefit of the economy of the village and the town, and I would support it whole-heartedly,” Lenore E. VanderZee said.

Ms. VanderZee, SUNY Canton’s executive director for university relations, said she was speaking only for herself but did point out that the college has incorporated cannabis business courses into its curriculum, recognizing the potential growth of the industry in New York.

Not allowing sales in Canton while other towns and villages go forward, would mean Canton would be missing out on the tax revenue from cannabis sales, Ms. VanderZee said.

Marti MacArthur also cited the potential revenue a dispensary would bring in her argument in favor of local sales.

“People in Canton, and certainly students, will be going to other villages,” she said.

Ms. MacArthur, a user of medical marijuana, said that before marijuana shops opened on the Akwesasne Reservation, she had to go to Plattsburgh to secure her medication.

“It would be great to have it here in Canton,” she said.

Marijuana has many benefits beyond its recreational use, she added.

“A lot of you would be very surprised that people you know use marijuana and have to go someplace else to get it,” Ms. MacArthur said.

“I am diametrically opposed to it,” Gerard Tozzi said.

Mr. Tozzi described finding hypodermic needles near the site of a halfway house in Canton.

“I don’t think it behooves us to introduce another form of dope into Canton,” he said.

As an Amazon Associate I earn from qualifying purchases.

Hemp Trade Group Sounds Alarm Over Minn. Court Ruling – Law360

By Katryna Perera (September 22, 2021, 8:54 PM EDT) — A hemp trade group has warned that a recent Minnesota appellate decision could devastate the local hemp industry because of its ruling that hemp-derived liquids that contain trace amounts of THC, the psychoactive ingredient found in marijuana, are controlled substances.

In a decision filed on Sept. 13, Minnesota Court of Appeals Judge Matthew E. Johnson upheld a drug conviction based on evidence of an unspecified amount of THC in vape liquid.

The case, Minnesota v. Loveless, resulted from a 2019 drug bust in which Jason Loveless was arrested by state troopers, in part, for possession of a controlled substance. According to…

Oregon regulators order CBD recall over impermissible THC levels – OregonLive

A Portland manufacturer of marijuana products has again run afoul of Oregon regulators over its ingredients.

The Oregon Liquor and Cannabis Commission ordered a recall this week of 1,000-milligram bottles of unflavored Select CBD Drops, labeled as “Broad Spectrum.” The drops contain too much of the psychoactive ingredient THC, according to the OLCC.

That poses a risk, the commission said, because unsuspecting consumers might get high on a product that isn’t supposed to have that effect.

“We are currently working closely with the OLCC, our testing laboratories and our labeling team to gather all facts and determine next steps,” Curaleaf, the company that owns the Select brand, said in a written statement. The company said the recalled batch is being removed from store shelves.

CBD, or cannabidiol, is derived from hemp but typically doesn’t have high levels of THC associated with recreational marijuana. Adherents use CBD as a wellness product, though its specific benefits haven’t been conclusively documented for many health applications.

The OLCC’s recall affects 500 products sold beginning June 19. The commission said about 200 units remain in retailers’ inventories and must now be quarantined. People who bought the product can return it to the store or simply destroy it.

Curaleaf said the recalled batch was only sold in Oregon. The company asked that people who bought the recalled Select drops contact Curaleaf at info.or@curaleaf.com.

Select ran afoul of the OLCC in 2020, too, for falsely claiming that a line of vaping products were 100% marijuana.

The state leveled a record $110,000 “dishonest conduct” penalty against Cura Cannabis, the Portland company that manufactured the Select product line. Cura’s former owners later settled a class-action lawsuit over the mislabeling, agreeing to pay $500,000.

Once Oregon’s biggest marijuana company, Cura was also among the state’s most troubled.

It obtained its initial funding from a notorious real-estate scam that sent a Lake Oswego investment manager to federal prison. And former Cura CEO Nitin Khanna quit in 2018 when women in the marijuana community highlighted a past rape allegation against him. Khanna denied the accusation but had settled a civil lawsuit in the case.

Cura sold last year to Massachusetts-based marijuana giant Curaleaf in an all-stock deal valued at the time at $400 million. Subsequent increases in Curaleaf’s share price have increased the value of the transaction.

— Mike Rogoway | mrogoway@oregonian.com | twitter: @rogoway | 503-294-7699

Global CBD Pet Market Report 2021-2028 Featuring Honest Paws, Canna-Pet, Fomo Bones, Pet Relief, HolistaPet, Joy Organics, Wet Noses, CBD Living, Pet stock, Petco, & Charlotte’s Web – Yahoo Finance

DUBLIN, Sept. 22, 2021 /PRNewswire/ — The „Global CBD Pet Market Size, Share & Trends Analysis Report 2021-2028” report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

Research and Markets Logo

The global CBD pet market size is expected to reach USD 4.79 billion by 2028. It is expected to expand at a CAGR of 58.9% from 2021 to 2028.

Increasing health expenditure and growing health concerns among the owners of domesticated animals are driving the market. In addition, increasing demand for cannabidiol (CBD) infused food products is boosting the market growth.

For instance, in 2019, Nestle owned Purina, a pet food company, broadcasted its decision to invest in CBD-infused dog food production. Furthermore, increased usage of natural supplements in treating various lifestyle-related disorders in domesticated animals is fueling the growth.

During the outbreak of COVID-19, the companion animal industry witnessed manufacturing challenges, comprising altered consumption patterns, improved demand, worker protection protocols, dearth of employees, and spot shortages in packaging, which affected the company’s business in the initial months of 2020.

However, sales growth figures driven by consumer demand and increased spending on pets permitted the industry to make a steep comeback in the latter of the year 2020. Paw CBD, cbdMD, Inc.’s pet brand has seen an estimated 64% increase in net sales from March 2020 quarter of about $750,000 to about $1,229,000 for June 2020 quarter.

The cannabidiol infused product is also found useful in cancer-related pain in animals. The rising adoption of domesticated animals and their increased health expenditure are further anticipated to put the market on expedited growth platforms in the coming few years. For instance, according to the National Pet Owners Survey 2019-2020 carried out by the American Pet Products Association (APPA), around 67.0% of U.S. households own a pet that constitutes 85.0 million families in the country.

The major players are focusing on the product innovation strategies due to the high awareness among pet owners and shifting preference toward natural pet supplements. Key players in the market are engaged in various strategies, such as new product developments and mergers & acquisitions, for better market penetration.

In May 2020, Puration, Inc. publicized its plans to close the purchase of a CBD-infused sun care product business. PURA targets CBD product acquisitions that can be improved with PURA’s patented technology, thereby strengthening its market position.

CBD Pet Market Report Highlights

  • The increased use of cannabidiol infused products and growing lifestyle-related disorders in companion animals are propelling the market growth

  • In the animal type segment, the vitamins and supplements segment dominated the market in 2020 owing to the increased product availability and consumption. Moreover, the growing popularity of supplements among humans as well as companion animals is propelling the demand

  • By indication, general health/wellness dominated the market in 2020. The growth can be attributed to the increasing pet healthcare expenditure and growing health concerns among the pet owners

  • The anxiety/stress indication segment is expected to witness the fastest growth over the forecast period owing to the increasing application of cannabidiol in anxiety-related disorders in companion animals

  • On the basis of end use, e-commerce held the largest revenue share in 2020 owing to product availability and ease of ordering

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 CBD Pet Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.4 CBD Pet: Market Analysis Tools
3.5 Regulatory Framework
3.6 Product Pipeline Analysis
3.7 Impact of Covid-19 in the Pet Market

Chapter 4 CBD Pet Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 CBD Pet Market Competitive Outlook
4.3 Public Companies
4.4 Private Companies

Chapter 5 CBD Pet Market: Segment Analysis, by Animal Type, 2016 – 2028 (USD Million)
5.1 Definition and Scope
5.2 Animal Type Market Share Analysis, 2020& 2028
5.3 Global CBD Pet Market, by Animal Type, 2016 to 2028
5.4 Market Size & Forecasts and Trend Analyses, 2016 to 2028
5.4.1 Dog
5.4.1.1 Dog, 2016 – 2028 (USD Million)
5.4.1.2 Foods/Treats
5.4.1.2.1. Foods/Treats, 2016 – 2028 (USD Million)
5.4.1.3 Vitamins & supplements
5.4.2 Cat
5.4.2.1 Cat, 2016 – 2028 (USD Million)
5.4.2.2 Foods/Treats
5.4.2.2.1 Foods/Treats, 2016 – 2028 (USD Million)
5.4.2.3 Vitamins & supplements

Chapter 6 CBD Pet Market: Segment Analysis, by Indication, 2016 – 2028 (USD Million)
6.1 Definition and Scope
6.2 Indication Market Share Analysis, 2020 & 2028
6.3 Global CBD Pet Market, by Indication, 2016 to 2028
6.4 Market Size & Forecasts and Trend Analyses, 2016 to 2028
6.4.1 Joint Pain
6.4.2 Anxiety/Stress
6.4.3 Epilepsy
6.4.4 General Health/Wellness

Chapter 7 CBD Pet Market: Segment Analysis, End Use, 2016 – 2028 (USD Million)
7.1 Definition and Scope
7.2 End-use Type Market Share Analysis, 2020& 2028
7.3 Global CBD Pet Market, End Use, 2016 to 2028
7.4 Market Size & Forecasts and Trend Analyses, 2016 to 2028
7.4.1 Pet specialty stores
7.4.2 E-commerce
7.4.3 CBD Store

Chapter 8 CBD Pet Market: Regional Market Analysis, by Animal type, Indication, and End Use, 2016 – 2028 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Snapshot
8.3 Market Size, & Forecasts, Volume and Trend Analysis, 2016 to 2028

Chapter 9 CBD Pet Market: Company Profiles

  • Honest Paws

  • Canna-Pet

  • Fomo Bones

  • Pet Relief

  • HolistaPet

  • Joy Organics

  • Wet Noses

  • CBD Living

  • Pet stock

  • Petco

  • Charlotte’s Web

For more information about this report visit https://www.researchandmarkets.com/r/dkd6l5

Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Cision

Cision

View original content:https://www.prnewswire.com/news-releases/global-cbd-pet-market-report-2021-2028-featuring-honest-paws-canna-pet-fomo-bones-pet-relief-holistapet-joy-organics-wet-noses-cbd-living-pet-stock-petco–charlottes-web-301383156.html

SOURCE Research and Markets

CBD Gummies For Tinnitus Shark Tank Reviews Ripoff Scam? – Santa Clarita Valley Signal

There is not a single person who has ample time to devote to his well-being. They are so engrossed in their professional lives that they do not get proper time to rest. Some people even work extra shifts that mean they do not get enough time to sleep and rest.  

Order Now CBD Gummies For Tinnitus  User’s Official Website 

Due to these habits, they develop poor sleeping and eating habits. All of these issues, when combined, create an imbalance in our lives and do not let us live our lives to the fullest. Working under a lot of stress and pressure and lack of proper sleep can lead to the physical and mental breakdown of a person. The most effective way to achieve good health is through the intake of CBD Gummies For Tinnitus Shark Tank. These gummies are infused with CBD that is processed from pure hemp and helps in the strengthening of our bodies.  

CBD Gummies For Tinnitus are all-natural CBD-infused gummies that have been formulated to positively affect the endocannabinoid system of the bodies of users. They will provide you with effective results that do not cause any adverse effects. These chewable candies are extremely delicious and very easy to consume. These gummies are formulated with natural and herbal ingredients and do not contain THC that eliminates the possibility of making you high. As a result, these CBD candies have no psychoactive or habit-forming effects and do not make you addicted to the use of these gummies.  

Check Here Available Discount Price For CBD Gummies For Tinnitus  

According to the manufacturer of CBD Gummies For Tinnitus, these CBD gummies positively impact our nervous system that helps in curing age-related cognitive decline. When the receptors of the nervous system get an abundance of nutrients then it helps in improving our focus, concentration, thinking capacity, and so on. As a nutritional health supplement, these CBD gummies are 100% organic, risk-free, and are totally safe to be used by individuals. You will get a lot of health benefits with the regular intake of these gummies. You just need to take them on a regular basis to see amazing results in your body. 

CBD Gummies For Tinnitus ingredients  

CBD Gummies For Tinnitus ingredients are 100% organic and have been proven scientifically to provide various medicinal benefits to users. Several types of research have been conducted on the efficiency of these ingredients and every time, they have proved their worth. They have been efficient in assisting our bodies to work properly by providing them with a lot of nutrients, vitamins, and minerals.  

       CBD Gummies For Tinnitus have the presence of these components- 

  1. CBD Gummies CBD Gummies Tinnitusis a natural tincture that is extracted from pure hemp and is very beneficial for our mental well-being. This ingredient helps in reducing the severity of various mental issues such as depression, stress, anxiety, and trauma. 
  1. Organic Fruit Pulp- This ingredient serves as a supplement of various nutrients that are required by our bodies to function properly. This pulp also gives a pleasant smell to these gummies. 
  1. Garcinia Cambogia- The reason why this ingredient has been included in these gummies is that it promotes rapid weight loss by enhancing the fat-burning process in our bodies. 
  1. Caffeine Anhydride- This ingredient can help in the prevention of cancer. It will also boost your energy levels by improving your metabolism and improves your overall well-being.  

How do CBD Gummies For Tinnitus work in our bodies? 

There is the presence of the ECS system in our bodies. All bodily functions should run and function properly is the responsibility of the ECS system. Inflammation, hunger, sleeping, and reflexes are some of the functions controlled by the ECS. Therefore, our ECS should perform flawlessly and should remain in a healthy state to keep our bodies free of any health issues. 

The CBD oil used in CBD Gummies For Tinnitus is unadulterated and has been processed naturally. This oil helps in delivering a lot of health benefits to the bodies of users without the use of any harmful substances. These gummies help you to maintain and live a healthy way of life naturally. 

These CBD-infused gummies start triggering the working of the ECS system and control various bodily activities such as sleep, eating, reflexes, concentration, and mobility with the support of natural and plant-based ingredients. Therefore, with the acceleration of smooth functioning of the ECS system, our bodies work properly.  

CBD Gummies For Tinnitus benefits  

  • CBD Gummies Tinnitus CBD-infused gummies contain anti-inflammatory properties that help our bodies get rid of inflammation and swelling. 
  • Maintain the health of the brain for improved concentration and focus. 
  • Reduce anxiety and stress levels and work to fix depression and panic attacks. 
  • CBD Gummies Tinnitus work to improve our cognitive health by slowing down the aging process. 
  • CBD Gummies Tinnitus improve the circulation of blood and prevent our bodies from suffering from high or low blood pressure. 
  • CBD Gummies Tinnitus prevent the growth of cancer and tumor cells. 
  • CBD Gummies Tinnitus work to enhance the texture of our skin. 
  • CBD Gummies Tinnitus will work to regulate your mood swings. 
  • CBD Gummies Tinnitus work to enhance our overall well-being. 
  • CBD Gummies Tinnitus promote the healthy functioning of our whole body.  

Product Information  

Name-           CBD Gummies For Tinnitus 

Role-             Cure mental and physical disorders 

Results-         In a few days of usage 

Dosage-         2 gummies per day 

Ingredients-   Plant-based ingredients 

Warning-       Keep out of reach of children 

Purchase-       From their Official Website 

Protocols for the users of CBD Gummies For Tinnitus 

  1. To get the best results, users must take these gummies on a regular basis. 
  1. Please shake the bottle thoroughly before opening it. 
  1. Please ensure that once the bottle has been opened, it must be kept away from direct sunlight and must be stored in a cool dry place. 
  1. People who have never used CBD products should start with a single dose and afterward, they can start taking two gummies in a day. 
  1. These gummies can be used by both men and women who are 18 years of age. 
  1. These gummies are not an ideal nutritional supplement for pregnant women and breastfeeding mothers. 

     Dosage   

  1. The recommended dosage for these gummies is 2 gummy bears as per the maker. 
  1. The best time to take these gummies is in the early morning and the late evening. 
  1. There should be a gap of a few hours in between the doses.  
  1. Please avoid the overdose on these gummies. 
  1. Take them regularly to get the best results. 
  1. Chew them properly before swallowing them to get the best results.  

How can you order CBD Gummies For Tinnitus? 

All those people who want to buy the package of CBD Gummies For Tinnitus must go through the official website of these gummies. On the website, you need to search for the option “Rush my order”, when you click on this option, you will be directed to a link to a form. You need to fill this form with all your essential details. 

Purchase CBD Gummies For Tinnitus  By Visiting Official Website 

After you will do this, your request will be accepted and your order will be placed and will be sent to your address.  

Please get in touch with the customer care team for further queries and clarifications. 

Final verdict  

If you are constantly tormented by various ailments and agonies of your body then CBD Gummies Tinnitus  will be the best approach for you to treat your body with the support system of natural and herbal extracts. These gummies will not impact your body in a negative way even if you will use them on a daily basis. If you wish to cure your body naturally then you can give these gummies a try and get your package of these gummies now! 

Curio Wellness Launches Retail Cannabis Franchise Far & Dotter – Franchise Times

Curio Wellness, the Maryland-based medical cannabis company, is the latest to launch a marijuana dispensary franchise, joining the likes of Unity Rd., The Open Dør, Miracle Leaf and others looking to make inroads in a challenging but potentially lucrative segment.

Dubbed Far & Dotter, a nod to the Swedish roots of Curio’s father-and-daughter founders, Michael and Wendy Bronfein, the franchise is targeting Florida, Illinois, Massachusetts, Maryland, Michigan, Missouri, New Jersey, Ohio, Pennsylvania and Virginia for expansion, states with “attractive medical programs,” said Wendy Bronfein and also some that have legalized recreational marijuana.  

Earlier this year Unity Rd. opened its first franchised marijuana store, illustrating the long road to franchising a cannabis brand.

Incorporating both a holistic pharmacy, which will sell vitamins, nutritional supplements and hemp-based cannabinoid, or CBD, products, and a cannabis dispensary, Far & Dotter retail locations represent “an evolution in the cannabis sector,” said Bronfein. Locations are designed to “break down the stigmas around this plant,” she continued, with flexible space to host educational events, removal of the traditional “waiting area” where customers are typically funneled after being checked in and “pod look rather than one long continuous counter” to allow for consultation and purchase transactions.

Wendy Bronfein, Curio Wellness

Wendy Bronfein is the co-founder, chief brand officer and director of public policy for Curio Wellness.

“We put a lot of thought not just into cannabis but where retail is going in general,” she said.

The cost to open a Far & Dotter location will range from about $500,000 to $1 million, including a $40,000 franchise fee and $10,000 construction management fee. That initial investment range does not include the cannabis license, which in its franchise disclosure document the company estimates will cost between $20,000 and $70,000. “State and local laws vary significantly in the procedures, difficulty, and cost associated with obtaining a Cannabis License,” the FDD reads.

Those higher startup costs, combined with federal banking regulations and a desire to combat diversity disparities within the cannabis industry, led to the creation of the Curio Wellness Investment Fund, aimed at helping minority entrepreneurs open their own medical cannabis franchise.

As part of the Far & Dotter franchise launch, Curio opened the application process for the fund, which thus far has raised $20 million, said Jerel Registre, managing director. A franchisee would contribute at least $40,000 to open the business, with the remaining amount provided through the investment fund via a combination of low interest fixed-rate loans and a direct equity investment for 40 percent ownership interest. Franchisees would then use cash flow from the business to buy out Curio’s equity investment.

Far & Dotter is looking for owner-operators, said Registre. “We want the person who cares the most walking through the door every day,” he said.

Jerel Registre, Curio Wellness

Jerel Registre is the managing director of the Curio Wellness Investment Fund.

Each franchise location will have a clinical director, “which matches with our brand positioning” and Far & Dotter’s goal of taking a clinical approach to addressing cannabis needs, continued Registre.

“The strains, they have, I’ll call it, different therapeutic effects” on the customer, he said, such as “fast onset and shorter duration versus a strain that takes longer to take effect.” A chronic pain patient “would look for a longer duration product, versus someone who is looking to unwind after a long day.”

As it undertakes franchise expansion, Bronfein said her hope is to take what Curio Wellness has learned since its start in 2014 to becoming a manufacturer and distributor of cannabis products with its own wellness center in Timonium, Maryland.

“There’s so many people who aspire to be here, but there’s so much you don’t know until you’re in it,” she said.

Curio Wellness recently closed a $22 million capital raise and secured a $26 million mortgage to expand its indoor cultivation at the Timonium headquarters’ cultivation facility.

What’s all the fuss about caregiver cannabis in Michigan? – City Pulse

Lansterdam in Review: H.B. 5300-5302

KYLE KAMINSKI

Hundreds of cannabis activists gathered at the State Capitol last week to push back against recently proposed state legislation that aims to reduce both the number of plants that medical marijuana caregivers can cultivate as well as the number of patients they can serve.

In the meantime, average pot-smoking customers across Michigan have been left wondering: What’s the point in this legislation? Does any of this affect me? And why should anyone care? As a service to our curious readers, I tapped the brakes on plans for a product review this week to break down the details — and potential impact — of the recently proposed state legislation.

The law:

State law allows licensed caregivers to cultivate up to 12 marijuana plants or purchase up to 2.5 ounces of product for up to five patients — enabling a harvest of up to 72 plants if the caregiver is also registered as a medical marijuana patient. Unlike licensed retailers, caregivers are not required to submit lengthy business plans to the state or pay as much in licensing fees. Their products also don’t have to be tested at one of the state’s 17 licensed state laboratories.

State records showed there are about 30,000 caregivers servicing more than 250,000 patients outside of the $1.47 billion licensed retail market in Michigan, including more than 1,200 caregivers and 8,600 patients across Greater Lansing in Ingham, Eaton and Clinton counties.

State officials said about 72,000 patients statewide are connected to a licensed caregiver. The other 178,000 patients can either grow from home or shop at medical and recreational stores.

The legislation:

House Bill 5300, 5301 and 5302,  introduced last week, comprise what lobbyists have labeled as the “Michigan Cannabis Safety Act.” The legislation would limit caregivers to growing a maximum of 24 plants by March 22, 2022 — 12 for themselves; 12 for one patient.

With 30,000 caregivers, that would reduce their maximum yield from 2.16 million plants to 720,000 plants that could be grown simultaneously among caregivers in Michigan. It would also reduce the legal limit on how much product they can each store at home from 15 to five ounces.

Additionally, the proposal would also require that cannabis cultivated by caregivers only be grown indoors and also be tested for product safety at a licensed laboratory. The legislation also sets up a new process for caregivers to sell their overages to licensed retailers and requires the state (and individual municipalities) to sign off on a new “Specialty Medical Grower” license.

The bipartisan bills were introduced by state reps. Jim Lilly, R-Park Township; Ronnie Peterson, D-Ypsilanti; TC Clements, R-Temperance; and Richard Steenland, D-Roseville. If the legislation makes its way out of the House Committee on Regulatory Reform, it will require a supermajority vote among lawmakers because they seek to amend a voter-approved initiative.

The proponents:

The Michigan Cannabis Manufacturers Association, the trade group leading the charge on proposed changes, is led by Steve Linder, a lobbyist and longtime GOP operative with a history of advocating for more stringent cannabis regulations. Among its board of directors are executives with High Life Farms, Skymint, LivWell and Common Citizen, which Linder has described as the “General Motors, Fords and Chryslers” of the weed business.

A public relations firm hired by the MCMA has refused to specifically identify its members.

The new rules are designed to promote safety, transparency and accountability for those participating in the state’s regulated cannabis market. They would also “rein in” the unlicensed cannabis industry, which “threatens the health of all Michiganders,” Lilly said in a statement.

The bills have also been sold as a way to cut back on “black market” sales, which account for more than $2 billion in unreported revenue annually, according to an MCMA-funded study.

The MCMA also funded a recent poll of 577 likely voters that found 82% of respondents had supported additional testing for caregivers, as well as 78% of respondents also supporting subjecting caregivers to the same level of state regulation as medical and recreational retailers.

The opponents: 

At least 300 cannabis companies across Michigan have come out swinging against any changes. Several companies have also distanced themselves from the MCMA after its plans went public — including Pleasantrees CEO Randy Buchman, who resigned from its board.

The state Department of Licensing and Regulatory Affairs is not promoting any changes. The Michigan Cannabis Industry Association (and its 300 members) also vowed in June to oppose the legislation before it was introduced. MCIA Director Robin Schneider said brands affiliated with the MCMA are “idiots” — namely for “spending a bunch of money and trying to ruin other people’s lives and your brands simultaneously,” she said on an episode of Jazz Cabbage Cafe.

Activists have argued that there is very little (if any) evidence to suggest that untested caregiver-grown pot creates any sort of public health risk. Rick Thompson, owner of the Michigan Cannabis Business Development Group, said the bills were instead motivated by greedy corporate cannabis brands who would rather not have the competition from caregivers.

Kyle Kaminski is City Pulse’s managing editor and a cannabis enthusiast who has been smoking marijuana just about every day for the last decade. Almost weekly, Kaminski samples some of the best cannabis products available in Greater Lansing, gets real high and writes about them. 

Support City Pulse  –  Donate Today!

First Pharmaceutical-grade, Ultra-High THC Vaporizer Products Just Weeks Away from Entering Canadian Cannabis Marketplace – Canada NewsWire

TORONTO, Sept. 22, 2021 /CNW/ – Kaiser Day Cannaceuticals, Ltd. an international medical cannabis company dedicated to providing pharmaceutical-grade medical cannabis, is just weeks away from launching its super-premium vaporizer products into the Canadian medical cannabis market space. Kaiser Day brings its pharmaceutical-grade, terpene-rich, full-spectrum cannabinoid vaporizer blends to patients and prescribers searching for better treatment options.

Only weeks before launching its full product line into the Canadian medical marketplace, Kaiser Day has announced it’s adding a fifth blend to its effect-specific product line. The new formulation is the first Ultra High-THC medical cannabis product to become available to patients across Canada.

The new vaporizer blend, named ASCEND, is an ultra-high THC formulation with a proprietary, effect-specific terpene profile. ASCEND’s energizing properties are suitable for conditions where a high-THC formulation is required for daytime use. In partnership with Northern Green Canada Inc., its Canadian Licensed Producer, the first vaporizer pens arrive in pharmacies in mid-October.

Kaiser Day Cannaceuticals, Ltd. was founded with the vision of creating pharmaceutical-grade, terpene-rich, cannabis-based medicines that are scientifically designed to achieve specific results for medical cannabis patients.

Kaiser Day formulates its medicines using the latest, cutting-edge clinical research on cannabinoids, terpenes, and their synergistic effects on the human body’s endocannabinoid system.

To be notified of the upcoming launch date, please visit the Kaiser Day website at kaiserday.com/

About Kaiser Day Cannaceuticals, Ltd.

As the developer of several clinically proven, pharmaceutical-grade cannabis products already being distributed in the Caribbean market, Kaiser Day aspires to be one of the world’s most-trusted cannabis pharmaceutical companies. It plans to bring its scientifically formulated, clinically proven, vaporizable medical cannabis products to countries whose laws permit the use and prescription of cannabis extracts for medical or therapeutic purposes.

SOURCE Kaiser Day Cannaceuticals

For further information: Media Relations, Kaiser Day Cannaceuticals, Ltd. [email protected]

Related Links

http://www.kaiserday.com/